INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

LOS ANGELES CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001177206)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 9,979 Value ($000) $730 Avg Close — Range —
Q2 2024
Shares 9,979 Value ($000) $683 Avg Close — Range —
Q1 2024
Shares 16,024 Value ($000) $1,109 Avg Close — Range —
Q4 2023
Shares 17,574 Value ($000) $1,259 Avg Close — Range —
Q3 2023
Shares 15,364 Value ($000) $800 Avg Close — Range —
Q2 2023
Shares 14,993 Value ($000) $949 Avg Close — Range —
Q1 2023
Shares 13,625 Value ($000) $738 Avg Close — Range —
Q4 2022
Shares 14,842 Value ($000) $785 Avg Close — Range —
Q3 2022
Shares 8,054 Value ($000) $375 Avg Close — Range —
Q4 2020
Shares 9,132 Value ($000) $290 Avg Close — Range —
Q4 2018
Shares 51,030 Value ($000) $581 Avg Close — Range —
Q3 2018
Shares 71,905 Value ($000) $1,560 Avg Close — Range —
Q2 2018
Shares 99,370 Value ($000) $1,756 Avg Close — Range —
Q2 2017
Shares 60,720 Value ($000) $754 Avg Close — Range —